Nandini Vijaisimha

Nandini Vijaisimha, with her deep-rooted expertise and passion, now stands as the Senior Director of India Corporate Affairs at MMS. In this pivotal role, she oversees and orchestrates the company’s corporate affairs strategies within the Indian context. Her activities encompass government and regulatory relations, corporate communications, and stakeholder engagement, ensuring that MMS’s values and objectives resonate in the region.

Her prior Director of Human Resources and Administration role has equipped her with a unique perspective, having managed cross-functional teams and strengthened HR processes. Nandini’s global interactions have allowed her to foster a cohesive alignment between teams scattered around the world, a skill she continues to leverage in her current role as she bridges MMS’s operations between India and its global counterparts.

Education and professional development have always been at the forefront of Nandini’s journey. She proudly holds a master’s diploma in Personnel Management and Industrial Relations from Bangalore University, India. Further amplifying her credentials, she also possesses an MBA in Human Resource Management from XLRI, Jamshedpur, India, and a bachelor’s degree in arts from Bangalore University. Her multiple HR certifications, coupled with international certification in executive coaching, serve as a testament to her unwavering commitment to ongoing education and professional excellence.

Beyond her academic and corporate achievements, Nandini boasts significant experience in coaching leaders, students, and professionals. Her expertise is particularly pronounced in the realm of Women Empowerment coaching, reflecting her dedicated approach to fostering growth and resilience in every individual she mentors.

Suggested For You

perspectives

December 17th, 2024

Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs

perspectives

December 11th, 2024

Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development